Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In a meta-analysis examining the efficacy of metformin treatment for GDM, it was found that the incidence of severe neonatal hypoglycemia was significantly reduced in the metformin-treated GDM group, potentially due to improved maternal glycemic management (Flory and Lipska, 2019
The results were modest at best and not clinically comparable to the effects of real GLP-1 medications like Ozempic, Wegovy, or Mounjaro
According to the American Diabetes Association (ADA), GLP-1 receptor agonists are now recommended as a first-line treatment in certain high-risk patients, especially those with established cardiovascular disease
Essential fatty acid metabolism in the micropremie
